Frontier Biotech and Kangsheng Global have reached a number of cooperation Consensus on the promotion of anti-infection diagnostic testing, and are committed to jointly promoting the improvement of the diagnosis and treatment level of infectious diseases in China.

This partnership ensures both companies can fully demonstrate their respective expertise to strengthen the concept of accurate detection and treatment in the field of infection, including improving the accessibility and standardization of HIV testing, improving the effective treatment rate and quality of life of the whole journey for people living with HIV (PLHIV).

Based on the anti-HIV experiences (both technical and channel), Frontier Biotech focuses on the whole life cycle of people living with HIV (PLHIV). Caring them from detection, prevention, and comprehensive treatment layout. The company aims to promote the improvement of HIV prevention and treatment, improve the overall impact and health condition through innovative antiviral treatment, and help the company diversify its revenue.